Published in Gene Therapy Weekly, April 8th, 2004
"The goal of this collaboration is to provide new therapeutic products for asthma, cancer, and other diseases, based on our combined efforts in genomics and biological research," said Roy C. Levitt, MD, Genaera's president and CEO. "We are extremely pleased to further our alliance with the world class investigators at the Ludwig Institute who originally identified IL-9 and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.